JBTM trades 26.4% below Wall Street's consensus target of $162.20.
Last 12 months price action with 12-month analyst target path
The base valuation assumes JBTM achieves its forward estimates and maintains a stable P/E multiple of 15.8x. This scenario reflects the blended consensus of 3 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 7, 2026, JBT Marel Corporation (JBTM) has a Wall Street consensus price target of $162.20, based on estimates from 3 covering analysts. With the stock currently trading at $128.35, this represents a potential upside of +26.4%. The company has a market capitalization of $6.68B.
Analyst price targets range from a low of $150.00 to a high of $175.00, representing a 15% spread in expectations. The median target of $165.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 3 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, JBTM trades at a trailing P/E of 33.8x and forward P/E of 15.8x. Analysts expect EPS to grow +120.8% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $96.50, with bear and bull scenarios of $60.80 and $127.15 respectively. Model confidence stands at 43/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 MIDDThe Middleby Corporation | $6.2B | $136.50 | $158.25 | +15.9% | Buy | 20.0x | 21 |
 FMCFMC Corporation | $705M | $5.63 | $11.35 | +101.6% | Hold | — | 42 |
 GEFGreif, Inc. | $3.3B | $72.51 | $90.67 | +25.0% | Hold | 16.7x | 14 |
 HLIHoulihan Lokey, Inc. | $10.2B | $145.86 | $159.80 | +9.6% | Buy | 18.9x | 16 |
 CECOCECO Environmental Corp. | $2.8B | $48.60 | $115.33 | +137.3% | Buy | 21.1x | 17 |
 TRMKTrustmark Corporation | $2.6B | $44.64 | $47.50 | +6.4% | Hold | 11.3x | 9 |
 PFGCPerformance Food Group Co | $16.9B | $107.50 | $128.17 | +19.2% | Buy | 19.1x | 27 |
 TSNTyson Foods, Inc. | $21.2B | $59.68 | $65.40 | +9.6% | Buy | 17.9x | 30 |
 HRLHormel Foods Corporation | $12.1B | $21.95 | $25.00 | +13.9% | Hold | 14.8x | 30 |
 CAGConagra Brands, Inc. | $7.3B | $15.24 | $13.75 | -9.8% | Hold | 9.0x | 25 |
Quick answers to the most common questions about buying JBTM stock.
The consensus Wall Street price target for JBTM is $162.2, representing 26.4% upside from the current price of $128.35. With 3 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
JBTM has a consensus rating of "Buy" based on 3 Wall Street analysts. The rating breakdown is predominantly bullish, with 3 Buy/Strong Buy ratings. The consensus 12-month price target of $162.2 implies 26.4% upside from current levels.
With a forward P/E of 15.795x, JBTM trades at a relatively low valuation. The consensus target of $162.2 implies 26.4% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $175 for JBTM, while the most conservative target is $150. The consensus of $162.2 represents the median expectation. Our quantitative valuation model projects a bull case target of $127 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
JBTM is lightly followed, with 3 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month JBTM stock forecast based on 3 Wall Street analysts shows a consensus price target of $162.2, with estimates ranging from $150 (bear case) to $175 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $97, with bear/bull scenarios of $61/$127.
Our quantitative valuation model calculates JBTM's fair value at $97 (base case), with a bear case of $61 and bull case of $127. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 43/100.
JBTM trades at a forward P/E ratio of 15.8x based on next-twelve-months earnings estimates compared to a trailing P/E of 33.8x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on JBTM, with a "Buy" consensus rating and $162.2 price target (26.4% upside). 3 of 3 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
JBTM analyst price targets range from $150 to $175, a 15% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $162.2 consensus represents the middle ground. Our model's $61-$127 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.